BioAtla
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $129,687,000.

Profit Margin

BioAtla, Inc. (NASDAQ:BCAB): Profit margin
2018 10.62M -28.97M -272.69%
2019 5.2M -31.40M -603.88%
2020 429K -37.24M -8680.89%
2021 250K -95.40M -38162.4%
2022 0 -105.28M
2023 0 -123.46M

BCAB Income Statement (2018 – 2023)

2023 2022 2021 2020 2019 2018
Revenue
Revenue
00250K429K5.2M10.62M
Cost of revenue
103.73M1.19M1.33M19.93K25.91K0
Gross profit
-103.73M-1.19M-1.08M409.06K5.17M10.62M
Operating exp.
Research and development
103.73M79.34M58.27M19.93M25.91M26.30M
Selling and marketing
000000
Total operating expenses
129.68M108.14M96.69M30.52M33.46M38.86M
Operating income
-129.68M-108.14M-96.44M-30.09M-28.26M-28.23M
Other income (expenses), net
6.22M1.65M1.03M-5.75M-1.58M-5K
Income before tax
-123.46M-106.48M-95.40M-35.85M-29.85M-28.97M
Income tax expense
0-1.19M4K1.38M1.54M204K
Net income
-123.46M-105.28M-95.40M-37.24M-31.40M-28.97M
Earnings per share
Basic EPS
-2.58-2.7-2.76-1.11-0.93-1.34
Diluted EPS
-2.58-2.7-2.76-1.11-0.93-1.34
Data sourceData sourceData sourceData source